Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Zevra Therapeutics (ZVRA) Return on Invested Capital: 2015-2025

Historic Return on Invested Capital for Zevra Therapeutics (ZVRA) over the last 3 years, with Sep 2025 value amounting to -0.31%.

  • Zevra Therapeutics' Return on Invested Capital was N/A to -0.31% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.31%, marking a year-over-year change of. This contributed to the annual value of -0.42% for FY2022, which is N/A change from last year.
  • According to the latest figures from Q3 2025, Zevra Therapeutics' Return on Invested Capital is -0.31%, which was down 136.86% from -0.13% recorded in Q2 2025.
  • In the past 5 years, Zevra Therapeutics' Return on Invested Capital registered a high of 0.06% during Q4 2021, and its lowest value of -0.77% during Q1 2024.
  • For the 3-year period, Zevra Therapeutics' Return on Invested Capital averaged around -0.28%, with its median value being -0.19% (2023).
  • Data for Zevra Therapeutics' Return on Invested Capital shows a maximum YoY slumped of 56bps (in 2024) over the last 5 years.
  • Zevra Therapeutics' Return on Invested Capital (Quarterly) stood at 0.06% in 2021, then fell by 23bps to -0.17% in 2022, then reached -0.17% in 2023, then tumbled by 56bps to -0.77% in 2024, then reached -0.31% in 2025.
  • Its Return on Invested Capital stands at -0.31% for Q3 2025, versus -0.13% for Q2 2025 and -0.77% for Q1 2024.